• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Newborn's fibrinolytic mechanism: components and plasmin generation.

作者信息

Corrigan J J, Sleeth J J, Jeter M, Lox C D

机构信息

Department of Pediatrics, University of Arizona Health Sciences Center, Tucson 85724.

出版信息

Am J Hematol. 1989 Dec;32(4):273-8. doi: 10.1002/ajh.2830320407.

DOI:10.1002/ajh.2830320407
PMID:2530897
Abstract

Plasminogen activity and antigen, tissue-type plasminogen activator (tPA) activity and antigen, plasminogen activator inhibitor (PAI) activity, and plasmin generation rates were determined in 32 normal newborn plasmas and 25 normal adult plasmas. The newborns showed reduced levels of plasminogen activity and antigen and tPA antigen, and activity, normal levels of PAI activity, and slower plasmin generation rates. The slower generation was shown to be due to the hypoplasminogenemia. The in vitro plasmin generation studies also showed that the newborn needed 11 times the usual concentration of urokinase and 5 times the usual concentration of tPA to achieve the minimal activation rate of the adult.

摘要

相似文献

1
Newborn's fibrinolytic mechanism: components and plasmin generation.
Am J Hematol. 1989 Dec;32(4):273-8. doi: 10.1002/ajh.2830320407.
2
Time dependent release of tissue-type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock.休克期间猪体内组织型纤溶酶原激活物和纤溶酶原激活物抑制剂随时间向循环系统的释放情况。
Blood Coagul Fibrinolysis. 1991 Jun;2(3):459-64. doi: 10.1097/00001721-199106000-00009.
3
Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.优球蛋白凝块溶解时间与组织型纤溶酶原激活物及纤溶酶原激活物抑制剂1血浆水平之间的关系。
Thromb Haemost. 1990 Feb 19;63(1):82-6.
4
Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns.
Pediatrics. 1992 Jan;89(1):43-6.
5
Plasminogen and plasmin activity in patients with coronary artery disease.冠状动脉疾病患者的纤溶酶原和纤溶酶活性
J Thromb Haemost. 2006 Jun;4(6):1288-95. doi: 10.1111/j.1538-7836.2006.01979.x.
6
The Role of Fibrinolytic System in Health and Disease.纤维蛋白溶解系统在健康和疾病中的作用。
Int J Mol Sci. 2022 May 9;23(9):5262. doi: 10.3390/ijms23095262.
7
A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.纤溶酶原激活物与抗纤溶因子之间的平衡发生改变,导致肝硬化患者纤溶活性增强。
Gastroenterology. 1991 Nov;101(5):1382-90. doi: 10.1016/0016-5085(91)90092-y.
8
TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.TM5275 延长了分泌型组织型纤溶酶原激活物的保留时间,并增强了血管内皮细胞的纤溶作用。
Thromb Res. 2013 Jul;132(1):100-5. doi: 10.1016/j.thromres.2013.04.003. Epub 2013 Apr 20.
9
The fibrinolytic system: A new target for treatment of depression with psychedelics.纤维蛋白溶解系统:治疗致幻剂所致抑郁症的新靶点。
Med Hypotheses. 2017 Mar;100:46-53. doi: 10.1016/j.mehy.2017.01.013. Epub 2017 Jan 23.
10
Myosin as cofactor and substrate in fibrinolysis.肌球蛋白作为纤维蛋白溶解中的辅助因子和底物。
FEBS Lett. 1997 Apr 21;407(1):93-6. doi: 10.1016/s0014-5793(97)00303-7.

引用本文的文献

1
Neonatal coagulopathies: A review of established and emerging treatments.新生儿凝血障碍:已确立和新兴治疗方法的综述。
Exp Biol Med (Maywood). 2021 Jun;246(12):1447-1457. doi: 10.1177/15353702211006046. Epub 2021 Apr 15.
2
Unilateral Renal Vein Thrombosis and Adrenal Hemorrhage in A Newborn with Homozygous Factor V Leiden and Heterozygous Of MTHFR-677T, MTHFR-1298C Gene Mutations.一名患有纯合子因子V莱顿突变及杂合子MTHFR-677T、MTHFR-1298C基因突变的新生儿出现单侧肾静脉血栓形成和肾上腺出血
Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):294-8. doi: 10.1007/s12288-014-0364-6. Epub 2014 Mar 15.
3
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
新生儿和儿童的抗血栓治疗:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.
4
Plasmin generation and fibrinolysis in pediatric patients undergoing cardiopulmonary bypass surgery.接受体外循环手术的儿科患者的纤溶酶生成与纤维蛋白溶解
Pediatr Cardiol. 2012 Feb;33(2):280-5. doi: 10.1007/s00246-011-0122-6. Epub 2011 Oct 2.
5
Hemostatic response in paediatric patients undergoing cardiopulmonary bypass surgery.接受体外循环手术的儿科患者的止血反应。
Pediatr Cardiol. 2011 Jun;32(5):621-7. doi: 10.1007/s00246-011-9929-4. Epub 2011 Mar 1.
6
Anticoagulation and thrombolysis in children.儿童抗凝与溶栓治疗
Tex Heart Inst J. 1992;19(3):168-77.
7
Neonatal portal vein thrombosis successfully treated by regional streptokinase infusion.通过局部输注链激酶成功治疗新生儿门静脉血栓形成。
Eur J Pediatr. 1994 Jun;153(6):456-9. doi: 10.1007/BF01983412.
8
Vascular compromise in newborn infants.新生儿的血管受损
Arch Dis Child. 1992 Apr;67(4 Spec No):463-7. doi: 10.1136/adc.67.4_spec_no.463.